LGM
Logos Global Management Portfolio holdings
AUM
$749M
This Quarter Return
+0.03%
1 Year Return
+18.94%
3 Year Return
+431.72%
5 Year Return
+481.1%
10 Year Return
–
AUM
$970M
AUM Growth
+$970M
(-30%)
Cap. Flow
-$201M
Cap. Flow
% of AUM
-20.76%
Top 10 Holdings %
Top 10 Hldgs %
49.08%
Holding
83
New
26
Increased
6
Reduced
23
Closed
17
Top Buys
| 1 |
Ventyx Biosciences
VTYX
|
$36.2M |
| 2 |
Repare Therapeutics
RPTX
|
$35.4M |
| 3 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$22M |
| 4 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$21.7M |
| 5 |
Cytokinetics
CYTK
|
$14.8M |
Top Sells
| 1 |
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
|
$62.9M |
| 2 |
Kezar Life Sciences
KZR
|
$44.3M |
| 3 |
PMV Pharmaceuticals
PMVP
|
$41.7M |
| 4 |
BCYC
Bicycle Therapeutics
BCYC
|
$36.8M |
| 5 |
Nkarta
NKTX
|
$35.5M |
Sector Composition
| 1 | Healthcare | 99.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Shattuck Labs
STTK
$61.3M
| – | – |
-200,000
| Closed | -$4.08M |
|
77
Synlogic
SYBX
$17.4M
| – | – |
-100,000
| Closed | -$4.58M |
|
78
Instil Bio
TIL
$196M
| – | – |
-63,855
| Closed | -$22.8M |
|
79
Viridian Therapeutics
VRDN
$1.59B
| – | – |
-1,500,000
| Closed | -$24.7M |
|
|
DCPH
80
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| – | – |
-1,850,000
| Closed | -$62.9M |
|
|
KNTE
81
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| – | – |
-94,345
| Closed | -$2.17M |
|
|
BCEL
82
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| – | – |
-1,175,000
| Closed | -$7.32M |
|
|
ARNA
83
DELISTED
Arena Pharmaceuticals Inc
ARNA
| – | – |
-510,000
| Closed | -$30.4M |
|